Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-27T20:53:12.543Z Has data issue: false hasContentIssue false

Chapter 36 - Persistent Pulmonary Hypertension of the Newborn

from Section 4 - Specific Conditions Associated with Fetal and Neonatal Brain Injury

Published online by Cambridge University Press:  13 December 2017

By
Robin H. Steinhorn
Edited by
David K. Stevenson ,
William E. Benitz ,
Philip Sunshine ,
Susan R. Hintz  and
Maurice L. Druzin
David K. Stevenson
Affiliation:
Stanford University, California
William E. Benitz
Affiliation:
Stanford University, California
Philip Sunshine
Affiliation:
Stanford University, California
Susan R. Hintz
Affiliation:
Stanford University, California
Maurice L. Druzin
Affiliation:
Stanford University, California
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Fetal and Neonatal Brain Injury , pp. 566 - 582
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Walsh-Sukys, MC, Tyson, JE, Wright, LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000; 105: 14–20Google Scholar
Kumar, VH, Hutchison, AA, Lakshminrusimha, S, et al. Characteristics of pulmonary hypertension in preterm neonates. J Perinatol 2007; 27: 214–9.Google Scholar
Aikio, O, Metsola, J, Vuolteenaho, R, et al. Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. J Pediatr 2012; 161: 397–403.CrossRefGoogle ScholarPubMed
Cerro, MJ, Abman, S, Diaz, G, et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ 2011; 1: 286–98.Google Scholar
Ivy, DD, Abman, SH, Barst, RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol 2013; 62: D117–26.Google Scholar
Teitel, DF, Iwamoto, HS, Rudolph, AM. Changes in the pulmonary circulation during birth-related events. Pediatr Res 1990; 27: 372–8.Google Scholar
Bloch, KD, Filippov, G, Sanchez, LS, et al. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol 1997; 272: L400–6.Google ScholarPubMed
Hanson, KA, Ziegler, JW, Rybalkin, SD, et al. Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. Am J Physiol 1998; 275: L931–41.Google Scholar
Sanchez, LS, de la Monte, SM, Filippov, G, et al. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr Res 1998; 43: 163–8.Google Scholar
Hernandez-Diaz, S, Van Marter, LJ, Werler, MM, et al. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 2007; 120: e272–82.Google Scholar
Delaney, C, Gien, J, Grover, TR, et al. Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus. Am J Physiol Lung Cell Mol Physiol 2011; 301: L937–44.Google Scholar
Delaney, C, Gien, J, Roe, G, et al. Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 2013; 304: L894–901.Google Scholar
Belik, J. Fetal and neonatal effects of maternal drug treatment for depression. Semin Perinatol 2008; 32: 350–4.Google Scholar
Fornaro, E, Li, D, Pan, J, Belik, J. Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. Am J Respir Crit Care Med 2007; 176: 1035–40.Google Scholar
Hybrechts, KF, Bateman, BT, Palmsten, K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA 2015; 313: 2142–51.Google Scholar
Kieler, H, Artama, M, Engeland, A, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012; 344: d8012.Google Scholar
Grigoriadis, S, Vonderporten, EH, Mamisashvili, L, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ (Clin Res Ed) 2014; 348: f6932.Google Scholar
Wilson, KL, Zelig, CM, Harvey, JP, et al. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors. Am J Perinatol 2011; 28: 19–24.Google Scholar
Andrade, SE, McPhillips, H, Loren, D, et al. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2009; 18: 246–52.Google Scholar
Lim, K, Sanders, A, Brain, U, et al. Third trimester fetal pulmonary artery Doppler blood flow velocity characteristics following prenatal selective serotonin reuptake inhibitor (SSRI) exposure. Early Hum Dev 2012; 88: 609–15.Google Scholar
Talati, AJ, Salim, MA, Korones, SB. Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am J Physiol 2000; 17: 69–71.Google Scholar
Wild, LM, Nickerson, PA, Morin, FC 3rd. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 1989; 25: 251–7.CrossRefGoogle ScholarPubMed
Van Marter, LJ, Hernandez-Diaz, S, Werler, MM, et al. Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics 2013; 131: 79–87.Google Scholar
Shah, PS, Hellmann, J, Adatia, I. Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn. J Perinat Med 2004; 32: 168–70.Google Scholar
Cua, CL, Blankenship, A, North, AL, et al. Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol 2007; 28: 250–4.Google Scholar
Weijerman, ME, van Furth, AM, van der Mooren, MD, et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 2010; 169: 1195–9.Google Scholar
Southgate, WM, Annibale, DJ, Hulsey, TC, Purohit, DM. International experience with trisomy 21 infants placed on extracorporeal membrane oxygenation. Pediatrics 2001; 107: 549–52.Google Scholar
Byers, HM, Dagle, JM, Klein, JM, et al. Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn. Pediatr Res 2012; 71: 162–7.Google Scholar
Chandrasekar, I, Eis, A, Konduri, GG. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension. Pediatr Res 2008; 63: 67–72.Google Scholar
Perez, M, Lakshminrusimha, S, Wedgwood, S, et al. Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 2011; 302(6): L595–603.CrossRefGoogle ScholarPubMed
Lapointe, A, Barrington, KJ. Pulmonary hypertension and the asphyxiated newborn. J Pediatr 2011; 158: e19–24.Google Scholar
Cornish, JD, Dreyer, GL, Snyder, GE, et al. Failure of acute perinatal asphyxia or meconium aspiration to produce persistent pulmonary hypertension in a neonatal baboon model. Am J Obstet Gynecol 1994; 171: 43–9.Google Scholar
Murphy, JD, Vawter, GF, Reid, LM. Pulmonary vascular disease in fatal meconium aspiration. J Pediatr 1984; 104: 758–62.Google Scholar
Toubas, PL, Hof, RP, Heymann, MA, Rudolph, AM. Effects of hypothermia and rewarming on the neonatal circulation. Arch Fr Pediatr 1978; 35: 84–92.Google Scholar
Thoresen, M. Hypothermia after perinatal asphyxia: selection for treatment and cooling protocol. J Pediatr 2011; 158: e45–9.Google Scholar
Sarkar, S, Barks, JD, Bhagat, I, et al. Pulmonary dysfunction and therapeutic hypothermia in asphyxiated newborns: whole body versus selective head cooling. Am J Perinatol 2009; 26: 265–70.Google Scholar
Shankaran, S, Laptook, AR, Pappas, A, et al. Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA 2014; 312: 2629–39.Google Scholar
Dodson, RB, Morgan, M, Galambos, C, et al. Chronic intrauterine pulmonary hypertension increases main pulmonary artery stiffness and adventitial remodeling in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2014; 307(11): L822–8.Google Scholar
Stenmark, KR, Davie, N, Frid, M, et al. Role of the adventitia in pulmonary vascular remodeling. Physiology 2006; 21: 134–45.Google Scholar
Stenmark, KR, Yeager, ME, El Kasmi, KC, et al. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol 2013; 75: 23–47.Google Scholar
Soifer, SJ, Kaslow, D, Roman, C, Heymann, MA. Umbilical cord compression produces pulmonary hypertension in newborn lambs: a model to study the pathophysiology of persistent pulmonary hypertension in the newborn. J Dev Physiol 1987; 9: 239–52.Google Scholar
Villaneuva, ME, Zaher, FM, Svinarich, DM, Konduri, GG. Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 1998; 44: 338–43.Google Scholar
Zagariya, A, Doherty, J, Bhat, R, et al. Elevated immunoreactive endothelin-1 levels in newborn rabbit lungs after meconium aspiration. Pediatr Crit Care Med 2002; 3: 297–302.Google Scholar
Soukka, H, Jalonen, J, Kero, P, Kaapa, P. Endothelin-1, atrial natriuretic peptide and pathophysiology of pulmonary hypertension in porcine meconium aspiration. Acta Paediatr 1998; 87: 424–8.Google Scholar
Soukka, H, Viinikka, L, Kaapa, P. Involvement of thromboxane A2 and prostacyclin in the early pulmonary hypertension after porcine meconium aspiration. Pediatr Res 1998; 44: 838–42.Google Scholar
Davis, AS, RW, D., Van Meurs, KP. Persistent pulmonary hypertension of the newborn. In Stevenson, DK, Benitz, WE, Sunshine, P, et al., eds., Fetal and Neonatal Brain Injury, 4th edn. Cambridge University Press, 2009: 419–42.Google Scholar
Steinhorn, RH, Russell, JA, Morin, FC 3rd. Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol 1995; 268: H1483–9.Google Scholar
de Buys Roessingh, A, Fouquet, V, Aigrain, Y, et al. Nitric oxide activity through guanylate cyclase and phosphodiesterase modulation is impaired in fetal lambs with congenital diaphragmatic hernia. J Pediatr Surg 2011; 46: 1516–22.Google Scholar
Chester, M, Seedorf, G, Tourneux, P, et al. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2011; 301: L755–64.Google Scholar
Kinsella, JP, Truog, WE, Walsh, WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997; 131: 55–62.Google Scholar
Wung, JT, James, LS, Kilchevsky, E, James, E. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation. Pediatrics 1985; 76: 488–94.Google Scholar
Lotze, A, Mitchell, BR, Bulas, DI, et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 1998; 132: 40–7.Google Scholar
Konduri, GG, Sokol, GM, Van Meurs, KP, et al. Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure. J Perinatol 2013; 33: 944–9.Google Scholar
Walsh-Sukys, MC, Tyson, JE, Wright, LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000; 105: 14–20.Google Scholar
Laffey, JG, Engelberts, D, Kavanaugh, BP. Inurious effects of hypocapnic alkalosis in the isolated lung. Am J Respir Crit Care Med 2000; 162: 399–405.Google Scholar
Marron, MJ, Crisafi, MA, Driscoll, JM Jr, et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. Pediatrics 1992; 90: 392–6.Google Scholar
Hendricks-Munoz, KD, Walton, JP. Hearing loss in infants with persistent fetal circulation. Pediatrics 1988; 81: 650–6.Google Scholar
Lakshminrusimha, S, Russell, JA, Steinhorn, RH, et al. Pulmonary hemodynamics in neonatal lambs resuscitated with 21%, 50%, and 100% oxygen. Pediatr Res 2007; 62: 313–8.Google Scholar
Lakshminrusimha, S, Swartz, DD, Gugino, SF, et al. Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension. Pediatr Res 2009; 66: 539–44.CrossRefGoogle ScholarPubMed
Clark, RH, Kueser, TJ, Walker, MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000; 342: 469–74.CrossRefGoogle ScholarPubMed
Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336: 597–604.Google Scholar
Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000; 136: 611–7.Google Scholar
Clark, RH, Huckaby, JL, Kueser, TJ, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 2003; 23: 300–3.Google Scholar
Farrow, KN, Lakshminrusimha, S, Czech, L, et al. SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2010; 299: L109–16.Google Scholar
Farrow, KN, Groh, BS, Schumacker, PT, et al. Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res 2008; 102: 226–33.CrossRefGoogle ScholarPubMed
Farrow, KN, Lee, KJ, Perez, M, et al. Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells. Antioxid Redox Signal 2012; 17: 460–70.Google Scholar
Baquero, H, Soliz, A, Neira, F, et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006; 117: 1077–83.Google Scholar
Steinhorn, RH, Kinsella, JP, Pierce, C, et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 2009; 155: 841–7.CrossRefGoogle ScholarPubMed
Keller, RL, Moore, P, Teitel, D, et al. Abnormal vascular tone in infants and children with lung hypoplasia: findings from cardiac catheterization and the response to chronic therapy. Pediatr Crit Care Med 2006; 7: 589–94.Google Scholar
Brannon, TS, MacRitchie, AN, Jaramillo, MA, et al. Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung. Am J Physiol 1998; 274: L66–71.Google Scholar
Brannon, TS, North, AJ, Wells, LB, Shaul, PW. Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest 1994; 93: 2230–5.Google Scholar
Christman, BW, McPherson, CD, Newman, JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70–5.Google Scholar
Lakshminrusimha, S, Porta, NF, Farrow, KN, et al. Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 2009; 10: 106–12.Google Scholar
Walmrath, D, Schneider, T, Schermuly, R, et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 153: 991–6.Google Scholar
Bindl, L, Fahnenstich, H, Peukert, U. Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal Ed 1994; 71: F214–6.Google Scholar
Soditt, V, Aring, C, Groneck, P. Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn. Intensive Care Med 1997; 23: 1275–8.Google Scholar
Olmsted, K, Oluola, O, Parthiban, A, Raghuveer, T. Can inhaled prostacyclin stimulate surfactant in ELBW infants? J Perinatol 2007; 27: 724–6.Google Scholar
Kelly, LK, Porta, NF, Goodman, DM, et al. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002; 141: 830–2.Google Scholar
Porta, NF, Steinhorn, RH. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. Clin Perinatol 2012; 39: 149–64.Google Scholar
Ferdman, DJ, Rosenzweig, EB, Zuckerman, WA, Krishnan, U. Subcutaneous treprostinil for pulmonary hypertension in chronic lung disease of infancy. Pediatrics 2014; 134: e274–8.Google Scholar
Luscher, TF. Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties. Am Rev Respir Dis 1992; 146: S56–60.Google Scholar
Perreault, T, Coceani, F. Endothelin in the perinatal circulation. Can J Physiol Pharmacol 2003; 81: 644–53.Google Scholar
Mann, J, Farrukh, IS, Michael, JR. Mechanisms by which endothelin 1 induces pulmonary vasoconstriction in the rabbit. J Appl Physiol 1991; 71: 410–6.Google Scholar
Ivy, DD, Kinsella, JP, Abman, SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 1994; 93: 2141–8.Google Scholar
Ivy, DD, Le Cras, TD, Horan, MP, Abman, SH. Chronic intrauterine pulmonary hypertension increases preproendothelin-1 and decreases endothelin B receptor mRNA expression in the ovine fetal lung. Chest 1998; 114: 65S.Google Scholar
Gien, J, Tseng, N, Seedorf, G, et al. Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res 2013; 73: 252–62.Google Scholar
Ivy, DD, Parker, TA, Ziegler, JW, et al. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 1997; 99: 1179–86.Google Scholar
Mohamed, WA, Ismail, M. A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn. J Perinatol 2012; 32(8): 608–13.Google Scholar
Steinhorn, RH, Fineman, J, Kusic-Pajic, A, et al. Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: results of the FUTURE-4 study. Circulation 2014; 130: A13503.Google Scholar
Reller, MD, Morton, MJ, Reid, DL, Thornburg, KL. Fetal lamb ventricles respond differently to filling and arterial pressures and to in utero ventilation. Pediatr Res 1987; 22: 621–6.Google Scholar
Cheung, PY, Barrington, KJ. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care 2001; 5: 158–66.Google Scholar
James, AT, Corcoran, JD, McNamara, PJ, et al. The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension. Cardiol Young 2015:1–10.Google Scholar
McNamara, PJ, Shivananda, SP, Sahni, M, et al. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. Pediatr Crit Care Med 2013; 14: 74–84.Google Scholar
Chen, B, Lakshminrusimha, S, Czech, L, et al. Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep. Pediatr Res 2009; 66: 682–7.Google Scholar
Mohamed, A, Nasef, N, Shah, V, McNamara, PJ. Vasopressin as a rescue therapy for refractory pulmonary hypertension in neonates: case series. Pediatr Crit Care Med 2014; 15: 148–54.Google Scholar
Paden, ML, Rycus, PT, Thiagarajan, RR. Update and outcomes in extracorporeal life support. Semin Perinatol 2014; 38: 65–70.Google Scholar
Bifano, EM, Pfannenstiel, A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics 1988; 81: 657–61.Google Scholar
Hageman, JR, Dusik, J, Keuler, H, et al. Outcome of persistent pulmonary hypertension in relation to severity of presentation. Am J Dis Child 1988; 142: 293–6.Google Scholar
Lipkin, PH, Davidson, D, Spivak, L, et al. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2002; 140: 306–10.Google Scholar
Konduri, GG, Vohr, B, Robertson, C, et al. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr 2007; 150: 235–40.Google Scholar
Fliman, PJ, deRegnier, RA, Kinsella, JP, et al. Neonatal extracorporeal life support: impact of new therapies on survival. J Pediatr 2006; 148: 595–9.CrossRefGoogle ScholarPubMed
Massaro, AN. MRI for neurodevelopmental prognostication in the high-risk term infant. Semin Perinatol 2015; 39: 159–67.Google Scholar
Rollins, MD, Yoder, BA, Moore, KR, et al. Utility of neuroradiographic imaging in predicting outcomes after neonatal extracorporeal membrane oxygenation. J Pediatr Surg 2012; 47: 76–80.Google Scholar
Gannon, CM, Kornhauser, MS, Gross, GW, et al. When combined, early bedside head ultrasound and electroencephalography predict abnormal computerized tomography or magnetic resonance brain images obtained after extracorporeal membrane oxygenation treatment. J Perinatol 2001; 21: 451–5.Google Scholar
Pappas, A, Shankaran, S, Stockmann, PT, Bara, R. Changes in amplitude-integrated electroencephalography in neonates treated with extracorporeal membrane oxygenation: a pilot study. J Pediatr 2006; 148: 125–7.Google Scholar
van Heijst, AF, de Mol, AC, Ijsselstijn, H. ECMO in neonates: neuroimaging findings and outcome. Semin Perinatol 2014; 38: 104–13.Google Scholar
UK Collaborative ECMO Trial Group. The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age. Pediatrics 1998; 101: E1.Google Scholar
Bennett, CC, Johnson, A, Field, DJ, Elbourne, D. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet 2001; 357: 1094–6.Google Scholar
McNally, H, Bennett, CC, Elbourne, D, Field, DJ. United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation: follow-up to age 7 years. Pediatrics 2006; 117: e845–54.Google Scholar
Ijsselstijn, H, van Heijst, AF. Long-term outcome of children treated with neonatal extracorporeal membrane oxygenation: increasing problems with increasing age. Semin Perinatol 2014; 38: 114–21.Google Scholar
Paden, ML, Conrad, SA, Rycus, PT, Thiagarajan, RR. Extracorporeal life support organization registry report 2012. ASAIO J 2013; 59: 202–10.Google Scholar
Parish, AP, Bunyapen, C, Cohen, MJ, et al. Seizures as a predictor of long-term neurodevelopmental outcome in survivors of neonatal extracorporeal membrane oxygenation (ECMO). J Child Neurol 2004; 19: 930–4.Google Scholar
Campbell, LR, Bunyapen, C, Gangarosa, ME, et al. Significance of seizures associated with extracorporeal membrane oxygenation. J Pediatr 1991; 119: 789–92.Google Scholar
Vaucher, YE, Dudell, GG, Bejar, R, Gist, K. Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation. J Pediatr 1996; 128: 109–17.Google Scholar
Kornhauser, MS, Baumgart, S, Desai, SA, et al. Adverse neurodevelopmental outcome after extracorporeal membrane oxygenation among neonates with bronchopulmonary dysplasia. J Pediatr 1998; 132: 307–11.Google Scholar
Van Meurs, KP, Nguyen, HT, Rhine, WD, et al. Intracranial abnormalities and neurodevelopmental status after venovenous extracorporeal membrane oxygenation. J Pediatr 1994; 125: 304–7.Google Scholar
Desai, SA, Stanley, C, Gringlas, M, et al. Five-year follow-up of neonates with reconstructed right common carotid arteries after extracorporeal membrane oxygenation. J Pediatr 1999; 134: 428–33.Google Scholar
Desai, S, Kollros, PR, Graziani, LJ, et al. Sensitivity and specificity of the neonatal brain-stem auditory evoked potential for hearing and language deficits in survivors of extracorporeal membrane oxygenation. J Pediatr 1997; 131: 233–9.Google Scholar
Cheung, PY, Robertson, CM. Sensorineural hearing loss in survivors of neonatal extracorporeal membrane oxygenation. Pediatr Rehabil 1997; 1: 127–30.Google Scholar
Joint Committee on Infant Hearing. Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007; 120: 898–921.Google Scholar
Beardsmore, C, Dundas, I, Poole, K, et al. Respiratory function in survivors of the UK Extracorporeal Membrane Oxygenation Trial. Am J Respir Crit Care Med 2000; 161: 1129–35.Google Scholar
Majaesic, CM, Jones, R, Dinu, IA, et al. Clinical correlations and pulmonary function at 8 years of age after severe neonatal respiratory failure. Pediatr Pulmonol 2007; 42: 829–37.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×